AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
201.31
-7.86 (-3.76%)
At close: Mar 25, 2025, 4:00 PM
201.41
+0.10 (0.05%)
After-hours: Mar 25, 2025, 6:11 PM EST
AbbVie Employees
AbbVie had 55,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.00% compared to the previous year.
Employees
55,000
Change (1Y)
5,000
Growth (1Y)
10.00%
Revenue / Employee
$1,024,255
Profits / Employee
$77,055
Market Cap
356.11B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 55,000 | 5,000 | 10.00% |
Jan 31, 2024 | 50,000 | 0 | - |
Jan 31, 2023 | 50,000 | 0 | - |
Jan 31, 2022 | 50,000 | 3,000 | 6.38% |
Jan 31, 2021 | 47,000 | 17,000 | 56.67% |
Jan 31, 2020 | 30,000 | 0 | - |
Jan 31, 2019 | 30,000 | 1,000 | 3.45% |
Jan 31, 2018 | 29,000 | -1,000 | -3.33% |
Jan 31, 2017 | 30,000 | 2,000 | 7.14% |
Jan 31, 2016 | 28,000 | 2,000 | 7.69% |
Jan 31, 2015 | 26,000 | 1,000 | 4.00% |
Jan 31, 2014 | 25,000 | 3,500 | 16.28% |
Jan 31, 2013 | 21,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ABBV News
- 4 days ago - 2025 Dividend Kings: Strong Run Continues - Seeking Alpha
- 5 days ago - My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys - Seeking Alpha
- 7 days ago - Widely used drugs on US imports list from Europe - Reuters
- 10 days ago - ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients - PRNewsWire
- 11 days ago - Drugmakers agree to participate in second round of price negotiations - Reuters
- 12 days ago - AbbVie Is Preparing To Challenge Eli Lilly And Novo Nordisk - Seeking Alpha
- 14 days ago - Stocks beating the stock market's recent Trump slump have this in common - Market Watch
- 14 days ago - AbbVie Inc. (ABBV) Leerink Partners Global Healthcare Conference (Transcript) - Seeking Alpha